Why This Study Matters
Many adults with ADHD also experience conditions like anxiety, depression, or substance use disorders. Understanding how ADHD medications affect these overlapping challenges is important when planning treatment.
What the Study Looked At
This systematic review examined research on several ADHD medications—including methylphenidate, atomoxetine, lisdexamfetamine, and bupropion—in adults who also had other psychiatric conditions.
Key Findings
• ADHD medications reliably improved core ADHD symptoms.
• Evidence that medications improve co-occurring conditions was mixed.
• Studies varied widely in design and patient populations.
• Functional improvements were not consistently reported.
My Take
Comorbidity is the rule rather than the exception in adult ADHD. This review highlights that while ADHD medications often help attention and impulsivity, they don’t automatically resolve other mental health issues. In practice, treatment usually requires a broader strategy that addresses both ADHD and co-occurring conditions. For some patients, treating ADHD can indirectly improve anxiety or mood by reducing daily stress and frustration. For others, targeted treatment for those conditions is still necessary. The key takeaway is that individualized treatment planning matters.
Source
Tripodi B, Carbone MG, Matarese I, Rizzato R, Della Rocca F, De Dominicis F, Callegari C. Effectiveness of Pharmacological Treatments for Adult ADHD on Psychiatric Comorbidity: A Systematic Review. J Clin Med. 2025 Dec 14;14(24):8848. doi: 10.3390/jcm14248848.
If you're seeking evaluation or treatment for adult ADHD in the Bay Area, learn more about our approach here.